Finerenone Alleviates Over-Activation of Complement C5a-C5aR1 Axis of Macrophages by Regulating G Protein Subunit Alpha i2 to Improve Diabetic Nephropathy
Cells · 26.02.2025 · 14 (5) · 337
DOI: 10.3390/cells14050337 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 26.02.2025. Verfasst von Zi-Han Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Renal Division, Department of Medicine, Peking University First Hospital, Beijing 100034, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Macrophages, Naphthyridines, Receptor, Anaphylatoxin C5a. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
Diabetic nephropathy (DN), one of the most common complications of diabetes mellitus (DM), accounts for a major cause of chronic kidney disease (CKD) worldwide, with a complicated pathogenesis and limited effective strategies nowadays. The mineralocorticoid receptor (MR) is a classical ligand-activated nuclear transcription factor. It is expressed in the renal intrinsic and immune cells, especially macrophages. Over-activation of the MR was observed in patients with DN and was associated with DN prognosis. The renoprotective role of a new generation of non-steroidal selective mineralocorticoid receptor antagonist (MRA), finerenone, has been confirmed in DM and CKD patients. However, the mechanism by which finerenone improves renal inflammation in DN has yet to be completely understood. It was found in this research that the oral administration of finerenone attenuated the kidney injuries in established DN in db/db mice, and particularly improved the pathological changes in the renal tubulointerstitia. Specifically, finerenone inhibited the over-activation of the MR in macrophages, thereby reducing the expression of G protein subunit alpha i2 (GNAI2, Gnαi2), a key downstream component of the C5aR1 pathway. Animal experiments demonstrated that C5aR1 knockout alleviated renal injuries, confirming the critical pathogenic role of C5aR1 in DN. Moreover, finerenone mitigated inflammatory and chemotaxis responses by downregulating Gnαi2 in macrophages. These effects were reflected by reduced expressions of the pro-inflammatory chemokines CXCL15 and CCL2, the regulation of macrophage polarization and improvements in apoptosis. This study intends to understand the protective role of finerenone in DN, which is conducive to revealing the pathophysiological mechanism of DN and further optimizing the treatment of DN patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Renal Division, Department of Medicine, Peking University First Hospital, Beijing 100034, China.
- Peking University Institute of Nephrology, Beijing 100034, China.
- Key Laboratory of Renal Disease, Ministry of Health of China, Beijing 100034, China.
- Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Peking University, Ministry of Education, Beijing 100034, China.
- Department of Nephrology, Peking University First Hospital, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing 100034, China.
- Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing 100730, China.
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- CAMS Innovation Fund for Medical Sciences
- the National High Level Hospital Clinical Research Funding
- National Key R&D Program of China
- National Natural Science Foundation
- National High Level Hospital Clinical Research Funding (State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University)
- NSFC/RGC Joint Research Scheme
Zitieren
APA
Li, Z. H., Sun, Z. J., Tang, S. C. W., Zhao, M. H., Chen, M., & Chang, D. Y. (2025). Finerenone Alleviates Over-Activation of Complement C5a-C5aR1 Axis of Macrophages by Regulating G Protein Subunit Alpha i2 to Improve Diabetic Nephropathy. Cells, 14(5), 337. https://doi.org/10.3390/cells14050337
Vancouver
Li ZH, Sun ZJ, Tang SCW, Zhao MH, Chen M, Chang DY. Finerenone Alleviates Over-Activation of Complement C5a-C5aR1 Axis of Macrophages by Regulating G Protein Subunit Alpha i2 to Improve Diabetic Nephropathy. Cells. 2025;14(5):337. doi:10.3390/cells14050337
BibTeX
@article{Li2025,
author = {Li, Zi-Han and Sun, Zi-Jun and Tang, Sydney C W and Zhao, Ming-Hui and Chen, Min and Chang, Dong-Yuan},
title = {Finerenone Alleviates Over-Activation of Complement C5a-C5aR1 Axis of Macrophages by Regulating G Protein Subunit Alpha i2 to Improve Diabetic Nephropathy},
journal = {Cells},
year = {2025},
volume = {14},
number = {5},
pages = {337},
doi = {10.3390/cells14050337}
}
EUVIMED